This work is licensed under a Creative Commons Attribution 4.0 International License.
| DRACP ID | Peptide Name | Sequence | Sequence Length | Origin |
|---|---|---|---|---|
| DRACP02493 | P6V8-8N (SEQ ID NO:14 for Patent US 20030186868 A1) | RRREKQRPCDKPRR | 14 | Synthetic |
| DRACP02494 | P6V8-3NCS-1C (SEQ ID NO:17 for Patent US 20030186868 A1) | KGRGKRRREKQRPSDKPR | 18 | Synthetic |
| DRACP02495 | P6V8-3NCS-2C (SEQ ID NO:18 for Patent US 20030186868 A1) | KGRGKRRREKQRPSDKP | 17 | Synthetic |
| DRACP02496 | P6V8-3NCS (SEQ ID NO:20 for Patent US 20030186868 A1) | KGRGKRRREKQRPSDKPRR | 19 | Synthetic |
| DRACP02497 | AS-2 (SEQ ID NO:22 for Patent US 20030186868 A1) | RRPKGRAAARREKQRPSDKPRR | 22 | Synthetic |
| DRACP02498 | AS-3 (SEQ ID NO:23 for Patent US 20030186868 A1) | RRPKGRGKRAAAKQRPSDKPRR | 22 | Synthetic |
| DRACP02499 | P6V8-3NCSA1 (SEQ ID NO:24 for Patent US 20030186868 A1) | AGRGKRRREKQRPSDKPRR | 19 | Synthetic |
| DRACP02500 | P6V8-3NCSA5 (SEQ ID NO:25 for Patent US 20030186868 A1) | KGRGARRREKQRPSDKPRR | 19 | Synthetic |
| DRACP02501 | P6V8-3NCSA3 (SEQ ID NO:27 for Patent US 20030186868 A1) | KGAGKRRREKQRPSDKPRR | 19 | Synthetic |
| DRACP02502 | P6V8-3NCSA6 (SEQ ID NO:28 for Patent US 20030186868 A1) | KGRGKARREKQRPSDKPRR | 19 | Synthetic |
| DRACP02503 | P6V8-3NRGCS (SEQ ID NO:31 for Patent US 20030186868 A1) | KGRGKRRREKQGPSDKPRR | 19 | Synthetic |
| DRACP02504 | P6V8-3NCSA16,18,19 (SEQ ID NO:32 for Patent US 20030186868 A1) | KGRGKRRREKQRPSDAPAA | 19 | Synthetic |
| DRACP02505 | P6V8-3NCSA7,8,10 (SEQ ID NO:33 for Patent US 20030186868 A1) | KGRGKRAAEAQRPSDKPRR | 19 | Synthetic |
| DRACP02506 | P6V8-3NCSA7,8,12 (SEQ ID NO:34 for Patent US 20030186868 A1) | KGRGKRAAEKQAPSDKPRR | 19 | Synthetic |
| DRACP02507 | P6V8-3NCSA1,5,7,8,10 (SEQ ID NO:35 for Patent US 20030186868 A1) | AGRGARAAEAQRPSDKPRR | 19 | Synthetic |
| DRACP02508 | AS-5 (SEQ ID NO:39 for Patent US 20030186868 A1) | RRPKGRGKRRREKQRPSDAAAR | 22 | Synthetic |
| DRACP02509 | Chemokinostatin-1 | NGRKACLNPASPIVKKIIEKMLNS | 24 | Homo sapiens (CXCL1/Gro-α) |
| DRACP02510 | Chemokinostatin-3 | NGKKACLNPASPMVQKIIEKIL | 22 | Homo sapiens (CXCL3/Gro-γ) |
| DRACP02511 | Chemokinostatin-5 | NGKEICLDPEAPFLKKVIQKILD | 23 | Homo sapiens (CXCL5/ENA-78) |
| DRACP02512 | Chemokinostatin-6 | NGKQVCLDPEAPFLKKVIQKILDS | 24 | Homo sapiens (CXCL6/GCP-2) |
| DRACP02513 | Chemokinostatin-7 | DGRKICLDPDAPRIKKIVQKKL | 22 | Homo sapiens (CXCL7/PBP) |
| DRACP02514 | Chemokinostatin-8 | DGRELCLDPKENWVQRVVEKFLK | 23 | Homo sapiens (CXCL8/IL-8) |
| DRACP02537 | Cilengitide, EMD 121974 | RGDfX | 5 | RGD Fibronectin |
| DRACP02538 | ATN-161 | PHSCN | 5 | Fibronectin |
| DRACP02800 | CDAK | CXGRCLLIIKLAKLAKKLAKLAK | 23 | Synthetic |
| DRACP03025 | Puma-BH3 | EQWAREIGAQLRRMADDLNA | 20 | Synthetic |
| DRACP03026 | XXA1-BH3 | RPEIWYAQGLKRFGDEFNAYYAR | 23 | Synthetic |
| DRACP03027 | XXA4-BH3 | RPEIWYAQWLKRFGDQFNAYYAR | 23 | Synthetic |
| DRACP03028 | XXA1_Y2dI-BH3 | RPEIWIAQGLKRFGDEFNAYYAR | 23 | Synthetic |
| DRACP03029 | XXA1_G2gE-BH3 | RPEIWYAQELKRFGDEFNAYYAR | 23 | Synthetic |
This work is licensed under a Creative Commons Attribution 4.0 International License.